The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
NYS Entity Status
NYS Filing Date
AUGUST 06, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - BOULEVARD LIQUORS INC.
AROUND THE WEB
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
- NFL Eyes Liquor Advertisers
Tuesday Jun 6, 2017
There have been liquor ads on TV for some time -- but not on the NFL. That will change this year, when they join the ranks of beer marketers for the league. It's all part of trad TV's search for newadvertisers and revenue streams.
- Five Sites of New York’s L.G.B.T. History
Monday Jun 19, 2017
Jacob Riis Park, a Manhattan church, the Bum Bum Bar and more. In 360 degrees, visit five sites that helped shape New York City’s L.G.B.T. community and its history.
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
- New York City and James Blake Resolve Excessive-Force Claim
By BENJAMIN MUELLER - Wednesday Jun 21, 2017
As part of the deal with the former pro tennis player, the city will create a new position within the agency that investigates police misconduct.
- Ask the NY Giants: Socks with Sandals?
Tuesday Sep 15, 2015
- How Diddy went from drug dealer to rap’s Gatsby
By Hardeep Phull - Saturday Jun 24, 2017
Most businessmen will tell you that behind every success is a slew of failures. Sean Combs is no different. The 47-year-old New Yorker (a?k?a Puff Daddy, a?k?a Puffy, P. Diddy, Diddy) is worth around $820 million thanks to his successes in fashion, movies, TV, liquor branding and, of course, music. But as covered in the...
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]